Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00938769 · ClinicalTrials.gov registry record · NA

Enhanced Self-Efficacy Training

A NA study of Neoplasms, sponsored by Duke University.

Completed
Registry status
NA
Development phase
358
Enrollment target
1
Study location

NCT00938769 is a NA study of Neoplasms that has completed, run by Duke University. The registered enrollment target is 358 participants, below the 1,619-participant average among 158 other Neoplasms trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00938769, a NA study of Neoplasms, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
358 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to examine the effects of an enhanced caregiver training protocol that not only teaches informal caregivers knowledge and skills for managing patient symptoms, but also provides strategies for managing their own psychological distress. The investigators anticipate this training will increase caregivers' self-efficacy and improve important caregiver outcomes (depression, anxiety, burden, quality of life) and patient outcomes (symptom distress/intensity, depression, anxiety, and quality of life). The study will compare the effects of this protocol to an education control condition that equates for interventionist time and attention.

Conditions Studied

Interventions

  • OTHER Self-Efficacy Training for Caregivers
  • OTHER Comparison Conditions for Caregivers

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 358 participants
Start Date 2009-08
Est. Completion 2013-09
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT00938769

The ClinicalTrials.gov registry entry for NCT00938769 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 358 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,619-participant average among 158 other Neoplasms trials with a reported enrollment target (78% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which Self-Efficacy Training for Caregivers is the first listed.

NCT00938769 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT00938769 about?

NCT00938769 is a clinical study titled "Enhanced Self-Efficacy Training". The goal of this study is to examine the effects of an enhanced caregiver training protocol that not only teaches informal caregivers knowledge and skills for managing patient symptoms, but also provides strategies for managing their own psychological distress. The investigators anticipate this trai...

What is the current status of trial NCT00938769?

This trial is currently completed. It is a NA study. The enrollment target is 358 participants. The study started on 2009-08. Estimated completion is 2013-09.

What conditions does trial NCT00938769 study?

This clinical trial studies the following conditions: Neoplasms.

What interventions are being tested in trial NCT00938769?

The interventions under investigation include: Self-Efficacy Training for Caregivers (OTHER), Comparison Conditions for Caregivers (OTHER).

Who is sponsoring clinical trial NCT00938769?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00938769 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.